This unit covers fundamental features and current methods involved in the medicinal chemistry and drug development process. The unit emphasises on lead identification, lead optimisation and the introduction of new drugs into clinical practice. It deals with specific case studies that examine real life drug discovery projects and how a range of drug design techniques are applied in each case. Novel drug delivery systems (e.g. recombinant DNA technology, liposome, gene therapy, monoclonal antibodies etc.) are also covered in detail. In addition, the study of chemical structure as a determinant of both the physicochemical properties and biological activity (including metabolic fate) of drug molecules of both synthetic and natural origin are also covered in detail.
|Unit name||Medicinal Chemistry and Drug Development|
|College/School||College of Health and Medicine
School of Pharmacy and Pharmacology
|Coordinator||Doctor Rahul Patel|
|Available as student elective?||No|
|Delivered By||University of Tasmania|
|Location||Study period||Attendance options||Available to|
- International students
- Domestic students
Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
|Study Period||Start date||Census date||WW date||End date|
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).
Unit census dates currently displaying for 2021 are indicative and subject to change. Finalised census dates for 2021 will be available from the 1st October 2020.
- Demonstrate an understanding of fundamental and scientific principles of drug discovery and drug development in the context of the clinical application of medicines.
- Describe the available options and demonstrate appropriateness of various drug delivery methods and technology.
- Describe basic / advanced biological pathways of metabolism and excretion of drugs, and factors that influence these processes in determining the biological activity of drugs.
|Field of Education||Commencing Student Contribution 1||Grandfathered Student Contribution 1||Approved Pathway Course Student Contribution 2||Domestic Full Fee|
- Available as a Commonwealth Supported Place
- HECS-HELP is available on this unit, depending on your eligibility3
- FEE-HELP is available on this unit, depending on your eligibility4
1 Please refer here more information on student contribution amounts.
2 Information on eligibility and Approved Pathway courses can be found here
3 Please refer here for eligibility for HECS-HELP
4 Please refer here for eligibility for FEE-HELP
Please note: international students should refer to this page to get an indicative course cost.
PrerequisitesKRA113 AND KRA114
2-3 lectures per week
|Assessment||Examination 1 (30%)|Examination 2 (35%)|Examination 3 (35%)|
|Timetable||View the lecture timetable | View the full unit timetable|
Required readings will be listed in the unit outline prior to the start of classes.
|Links||Booktopia textbook finder|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.